Pathophysiology of the vascular wall and its relevance for cerebrovascular disorders in aged rodents

Current Neurovascular Research

Volumn 7, Issue 3, 2010, Pages 251-267

  Popa Wagner, Aurel ^a,b,e   Pirici, Daniel ^b   Petcu, Eugen Bogdan ^c   Mogoanta, Laurentiu ^b   Buga, Ana Maria ^b   Rosen, Charles L ^d   Leon, Rachel ^d   Huber, Jason D ^d  

^a Greifswald School of Medicine   (Germany)

^b UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^c GRIFFITH UNIVERSITY   (Australia)

^d WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Aging; Alzheimer's disease; Angiogenesis; Arteriogenesis; Blood brain barrier; Cerebral circulation; Cerebrovascular disorders; Stroke

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; ANGIOPOIETIN; ANGIOPOIETIN RECEPTOR; BETA CATENIN; BETA SECRETASE; C REACTIVE PROTEIN; CD31 ANTIGEN; CONGO RED; CYSTATIN C; DEXTRAN; FIBRINOGEN; GAMMA SECRETASE; GELATINASE A; GELSOLIN; NERVE CELL ADHESION MOLECULE; NEUROPILIN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PREALBUMIN; PRION PROTEIN; THIOFLAVINE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE PLASMINOGEN ACTIVATOR; UNINDEXED DRUG; UVOMORULIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

AGING; ALZHEIMER DISEASE; ANGIOGENESIS; ARTERY RUPTURE; BINDING AFFINITY; BLOOD BRAIN BARRIER; BLOOD VESSEL WALL; BRAIN BLOOD VESSEL; BRAIN CIRCULATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN TISSUE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; CONVALESCENCE; CORPUS CALLOSUM; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE MODEL; EXTRAVASATION; HEMANGIOBLAST; HUMAN; HYPERTENSION; IN VITRO STUDY; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); NERVE REGENERATION; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PERMEABILITY; PRIORITY JOURNAL; REVIEW; SCAR; STROKE; SUBARACHNOID HEMORRHAGE; SYSTOLIC BLOOD PRESSURE; TRAUMATIC BRAIN INJURY; VASCULAR AMYLOIDOSIS;

EID: 77956512195     PISSN: 15672026     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720210792231813     Document Type: Review

References (149)

1. Baquer NZ, Taha A, Kumar P, et al. A metabolic and functional overview of brain aging linked to neurological disorders. Biogerontology 2009; 10(4): 377-413.
2. Singh R, Sharma D. Electrophysiological ageing of the brain and pharmacology of ageing. Cellular and molecular brain ageing. New Delhi: M/s Narosa Publishers 2005.
3. Popa-Wagner A, Carmichael ST, Kokaia Z, Kessler C, Walker L.C. The response of the aged brain to stroke: Too much, too soon? Curr Neurovasc Res 2007; 4(3): 216-27.
4. Biagi L, Abbruzzese A, Bianchi MC, et al. Age dependence of cerebral perfusion assessed by magnetic resonance continuous arterial spin labeling. J Magn Reson Imaging 2007; 25(4): 696-702.
5. Marini AM, Choi J, Labutta R. Synaptic deprivation and agerelated vulnerability to hypoxic-ischemic neuronal injury. A hypothesis. Ann N Y Acad Sci 2001; 939: 238-53.
6. Davis, LE, King, MK, and Schultz, L.J. Fundamentals of neurologic disease. New York: Demos Medical Publishing 2005.
7. Xiong ZG, Chu XP, Simon RP. Acid sensing ion channels-novel therapeutic targets for ischemic brain injury. Front Biosci 2007; 12: 1376-86.
8. Durukan A, Tatlisumak T. Acute ischemic stroke: Overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 2007; 87(1): 179-97.
9. Georgakopoulos A, Litterst C, Ghersi E, et al. Metalloproteinase/ Presenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signaling. EMBO J 2006; 25(6): 1242-52.
10. Qureshi AI, Mendelow AD, Hanley D.F. Intracerebral haemorrhage. Lancet 2009; 373(9675): 1632-44.
11. Wang DZ, Talkad A.V. Treatment of intracerebral hemorrhage: What should we do now? Curr Neurol Neurosci Rep 2009; 9(1): 13-8.
12. Brott T, Thalinger K, Hertzberg V. Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke 1986; 17(6): 1078-83.
13. Hanggi D, Steiger H.J. Spontaneous intracerebral haemorrhage in adults: A literature overview. Acta Neurochir (Wien) 2008; 150(4): 371-9.
14. Geddes JW, Chang-Chui H, Cooper SM, Lott IT, Cotman C.W. Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease. Brain Res 1986; 399(1): 156-61.
15. Hansson GK, Jonasson L. The discovery of cellular immunity in the atherosclerotic plaque. Arterioscler Thromb Vasc Biol 2009; 29(11): 1714-7.
16. Oh H, Mohler ER, III, Tian A, Baumgart T, Diamond S.L. Membrane cholesterol is a biomechanical regulator of neutrophil adhesion. Arterioscler Thromb Vasc Biol 2009; 29(9): 1290-7.
17. Rubattu S, Gigante B, Stanzione R, et al. In the search for stroke genes: A long and winding road. Am J Hypertens 2004; 17(2): 197-202.
18. Vinters H.V. Cerebral amyloid angiopathy. A critical review. Stroke 1987; 18(2): 311-24.
19. Rost NS, Greenberg SM, Rosand J. The genetic architecture of intracerebral hemorrhage. Stroke 2008; 39(7): 2166-73.
20. Scholtz W. Studien zur Pathologie der Hirngefässe. I.I. Die drüsige Entartung der Hirnarterien und -capillären. Z Gesamte Neurol Psychiat 1938; 162: 694-715.
21. Revesz T, Ghiso J, Lashley T, et al. Cerebral amyloid angiopathies: A pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol 2003; 62(9): 885-98.
22. Revesz T, Holton JL, Lashley T, et al. Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol 2009; 118(1): 115-30.
23. Vinters HV, Wang ZZ, Secor D.L. Brain parenchymal and microvascular amyloid in Alzheimer's disease. Brain Pathol 1996; 6(2): 179-95.
24. Alzheimer A. Über eine eigenartige erkrankung der Hinrinde. Zentralblatt Nervenheilkunde Psychiatrie 1907; 18: 177-9.
25. Hardy J. A hundred years of Alzheimer's disease research. Neuron 2006; 52(1): 3-13.
26. Selkoe D.J. The cell biology of ß-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 1998; 8(11): 447-53.
27. Hardy J. The amyloid hypothesis for Alzheimer's disease: A critical reappraisal. J Neurochem 2009; 110(4): 1129-34.
28. Dickson D.W. The pathogenesis of senile plaques. J Neuropathol Exp Neurol 1997; 56(4): 321-39.
29. Glenner GG, Wong C.W. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984; 122: 885-90.
30. Goate A, Chartier HM, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349(6311): 704-6.
31. Mullan M, Crawford F, Axelman K, et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1992; 1(5): 345-7.
32. Hendriks L, van Duijn CM, Cras P, et al. Presenile dementia and cerebral haemorrhage linked to a mutation at condon 692 of the bamyloid precursor protein gene. Nat Genet 1992; 1: 218-21.
33. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing mis-sense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375: 754-60.
34. Levy-Lahad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 269(5226): 973-7.
35. Kamino K, Orr HT, Payami H, et al. Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am J Hum Genet 1992; 51: 998-1014.
36. Miravalle L, Tokuda T, Chiarle R, et al. Substitutions at codon 22 of Alzheimer's A{beta} peptide induce conformational changes and diverse apoptotic effects in human cerebral endothelial cells. J Biol Chem 2000; 275(35): 27110-6.
37. Levy E, Carman MD, Fernandez-Madrid IJ, et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990; 248(4959): 1124-6.
38. Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, Greenberg S.M. Novel amyloid precursor protein mutation in an iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 2001; 49: 697-705.
39. Jellinger K.A. Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases. Neurodegener Dis 2010; 7(1- 3): 112-5.
40. Itoh Y, Yamada M, Hayakawa M, Otomo E, Miyatake T. Cerebral amyloid angiopathy: A significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci 1993; 116(2): 135-41.
41. Preston SD, Steart PV, Wilkinson A, Nicoll JAR, Weller R.O. Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: Defining the perivascular route for the elimination of amyloid beta from the human brain. Neuropathol Appl Neurobiol 2003; 29(2): 106-17.
42. Wisniewski HM, Wegiel J. Beta-amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol (Berl) 1994; 87(3): 233-41.
43. Kumar-Singh S, Pirici D, McGowan E, et al. Dense core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls. Am J Pathol 2005; 167: 527-43.
44. Morel F, Wildi E. General and cellular pathochemistry of senile and presenile alterations of the brain. Proc Int Congr Neuropathol Rome 1952; 347-74.
45. Attems J, Jellinger K.A. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology-a pilot study. Acta Neuropathol (Berl) 2004; 107(2): 83-90.
46. Kumar-Singh S, Cras P, Wang R, et al. Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric. Am J Pathol 2002; 161(2): 507-20.
47. Vonsattel JP, Myers RH, Hedley-Whyte ET, et al. Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study. Ann Neurol 1991; 30(5): 637-49.
48. Kalaria RN, Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 1999; 13 (Suppl 3): S115-23.
49. Jellinger K.A. Vascular-ischemic dementia: An update. J Neural Transm Suppl 2002; (62): 1-23.
50. Roher AE, Kuo YM, Esh C, et al. Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease. Mol Med 2003; 9(3-4): 112-22.
51. Dermaut B, Kumar-Singh S, De Jonghe C, et al. Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation. Brain 2001; 124(Pt 12): 2383-92.
52. Peers MC, Lenders MB, Defossez A, Delacourte A, Mazzuca M. Cortical angiopathy in alzheimers-disease - the formation of dystrophic perivascular neurites is related to the exudation of amyloid fibrils from the pathological vessels. Virchows Arch A Pathol Anat Histopathol 1988; 414(1): 15-20.
53. Games D, Adams D, Alessandrini R, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F betaamyloid precursor protein. Nature 1995; 373(6514): 523-7.
54. Herzig MC, Winkler DT, Burgermeister P, et al. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci 2004; 7(9): 954-60.
55. De Jonghe C, Cras P, Vanderstichele H, et al. Evidence that Abeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype. Neurobiol Dis 1999; 6(4): 280-7.
56. Cheng IH, Palop JJ, Esposito LA, et al. Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation. Nat Med 2004; 10(11): 1190-2.
57. Davis J, Xu F, Deane R, et al. Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor. J Biol Chem 2004; 279(19): 20296-306.
58. Miao J, Xu F, Davis J, et al. Cerebral microvascular Aβ protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant AβPP. Am J Pathol 2005; 167(2): 505-15.
59. Hsiao K, Chapman P, Nilsen S, et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996; 274(5284): 99-102.
60. Sturchler-Pierrat C, Abramowski D, Duke M, et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 1997; 94(24): 13287-92.
61. Calhoun ME, Burgermeister P, Phinney AL, et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci USA 1999; 96(24): 14088-93.
62. Winkler DT, Bondolfi L, Herzig MC, et al. Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. J Neurosci 2001; 21(5): 1619-27.
63. Winkler DT, Biedermann L, Tolnay M, et al. Thrombolysis induces cerebral hemorrhage in a mouse model of cerebral amyloid angiopathy. Ann Neurol 2002; 51(6): 790-3.
64. Yamaguchi H, Yamazaki T, Lemere CA, Frosch MP, Selkoe D.J. Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study. Am J Pathol 1992; 141(1): 249-59.
65. Kawai M, Kalaria RN, Cras P, et al. Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Res 1993; 623(1): 142-6.
66. Natte R, de Boer WI, Maat-Schieman ML, et al. Amyloid beta precursor protein-mRNA is expressed throughout cerebral vessel walls. Brain Res 1999; 828(1-2): 179-83.
67. Verbeek MM, De Waal RM, Schipper JJ, Van Nostrand W.E. Rapid degeneration of cultured human brain pericytes by amyloid beta protein. J Neurochem 1997; 68(3): 1135-41.
68. Coma M, Guix FX, Ill-Raga G, et al. Oxidative stress triggers the amyloidogenic pathway in human vascular smooth muscle cells. Neurobiol Aging 2008; 29(7): 969-80.
69. Weller RO, Massey A, Newman TA, et al. Cerebral amyloid angiopathy: Amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol 1998; 153(3): 725-33.
70. Weller RO, Djuanda E, Yow HY, Carare R.O. Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol 2009; 117(1): 1-14.
71. Nicoll JAR, Yamada M, Frackowiak J, Mazur-Kolecka B, Weller R.O. Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease Pro-CAA position statement. Neurobiol Aging 2004; 25(5): 589-97.
72. Zlokovic B.V. Clearing amyloid through the blood-brain barrier. J Neurochem 2004; 89(4): 807-11.
73. Grady CL, Craik F.I. Changes in memory processing with age. Curr Opin Neurobiol 2000; 10(2): 224-31.
74. Clayton DA, Mesches MH, Alvarez E, Bickford PC, Browning M.D. A hippocampal NR2B deficit can mimic age-related changes in long-term potentiation and spatial learning in the Fischer 344 rat. J Neurosci 2002; 22(9): 3628-37.
75. Mesches MH, Gemma C, Veng LM, et al. Sulindac improves memory and increases NMDA receptor subunits in aged Fischer 344 rats. Neurobiol Aging 2004; 25(3): 315-24.
76. Navarro JC, Lao AY, Sharma VK, Tsivgoulis G, Alexandrov A.V. The accuracy of transcranial Doppler in the diagnosis of middle cerebral artery stenosis. Cerebrovasc Dis 2007; 23(5-6): 325-30.
77. Ay H, Koroshetz WJ, Vangel M, et al. Conversion of ischemic brain tissue into infarction increases with age. Stroke 2005; 36(12): 2632-6.
78. Dinapoli VA, Rosen CL, Nagamine T, Crocco T. Selective MCA occlusion: A precise embolic stroke model. J Neurosci Methods 2006; 154(1-2): 233-8.
79. Dinapoli VA, Huber JD, Houser K, Li X, Rosen C.L. Early disruptions of the blood-brain barrier may contribute to exacerbated neuronal damage and prolonged functional recovery following stroke in aged rats. Neurobiol Aging 2008; 29(5): 753-64.
80. Kelly KA, Li X, Tan Z, et al. NOX2 inhibition with apocynin worsens stroke outcome in aged rats. Brain Res 2009; 1292: 165-72.
81. Liu R, Wen Y, Perez E, et al. 17beta-Estradiol attenuates bloodbrain barrier disruption induced by cerebral ischemia-reperfusion injury in female rats. Brain Res 2005; 1060(1-2): 55-61.
82. Badan I, Buchhold B, Hamm A, et al. Accelerated glial reactivity to stroke in aged rats correlates with reduced functional recovery. J Cereb Blood Flow Metab 2003; 23(7): 845-54.
83. Popa-Wagner A, Dinca I, Yalikun S, et al. Accelerated delimitation of the infarct zone by capillary-derived nestin-positive cells in aged rats. Curr Neurovasc Res 2006; 3(1): 3-13.
84. Jucker M, Walker LC, Schwarb P, et al. Age-related deposition of glia-associated fibrillar material in brains of C57BL/6 mice. Neuroscience 1994; 60(4): 875-89.
85. Frisen J, Johansson CB, Torok C, Risling M, Lendahl U. Rapid, widespread, and longlasting induction of nestin contributes to the generation of glial scar tissue after CNS injury. J Cell Biol 1995; 131(2): 453-64.
86. Peters A. The effects of normal aging on myelin and nerve fibers: A review. J Neurocytol 2002; 31(8-9): 581-93.
87. Yu WH, Go L, Guinn BA, et al. Phenotypic and functional changes in glial cells as a function of age. Neurobiol Aging 2002; 23(1): 105-15.
88. Castillo-Ruiz MM, Campuzano O, Acarin L, Castellano B, Gonzalez B. Delayed neurodegeneration and early astrogliosis after excitotoxicity to the aged brain. Exp Gerontol 2007; 42(4): 343-54.
89. Rozovsky I, Wei M, Morgan TE, Finch C.E. Reversible age impairments in neurite outgrowth by manipulations of astrocytic GFAP. Neurobiol Aging 2005; 26(5): 705-15.
90. Duggal N, Schmidt-Kastner R, Hakim A.M. Nestin expression in reactive astrocytes following focal cerebral ischemia in rats. Brain Res 1997; 768(1-2): 1-9.
91. Li Y, Chopp M. Temporal profile of nestin expression after focal cerebral ischemia in adult rat. Brain Res 1999; 838(1-2): 1-10.
92. Schwab JM, Beschorner R, Nguyen TD, Meyermann R, Schluesener H.J. Differential cellular accumulation of connective tissue growth factor defines a subset of reactive astrocytes, invading fibroblasts, and endothelial cells following central nervous system injury in rats and humans. J Neurotrauma 2001; 18(4): 377-88.
93. Tonchev AB, Yamashima T, Zhao L, Okano HJ, Okano H. Proliferation of neural and neuronal progenitors after global brain ischemia in young adult macaque monkeys. Mol Cell Neurosci 2003; 23(2): 292-301.
94. Goldman S. Glia as neural progenitor cells. Trends Neurosci 2003; 26(11): 590-6.
95. Holley JE, Gveric D, Newcombe J, Cuzner ML, Gutowski N.J. Astrocyte characterization in the multiple sclerosis glial scar. Neuropathol Appl Neurobiol 2003; 29(5): 434-44.
96. Gerzanich V, Ivanova S, van der Heijden MS, Zhou H, Simard J.M. Trans-cellular proliferating cell nuclear antigen gene activation in cerebral vascular smooth muscle by endothelial oxidative injury in vivo. Arterioscler Thromb Vasc Biol 2003; 23(11): 2048-54.
97. Farkas E, Luiten PG.M. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 2001; 64(6): 575-611.
98. Riddle DR, Sonntag WE, Lichtenwalner R.J. Microvascular plasticity in aging. Ageing Res Rev 2003; 2(2): 149-68.
99. Hajdu MA, Heistad DD, Siems JE, Baumbach G.L. Effects of aging on mechanics and composition of cerebral arterioles in rats. Circ Res 1990; 66(6): 1747-54.
100. Ritter L. Ischemia-reperfusion injury after stroke: From mechanisms to a nursing process. Nurs Sci Q 2008; 21(1): 41-2.
101. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 2002; 8(9): 963-70.
102. Thored P, Arvidsson A, Cacci E, et al. Persistent production of neurons from adult brain stem cells during recovery after stroke. Stem Cells 2006; 24(3): 739-47.
103. Morris DC, Chopp M, Zhang L, Zhang Z.G. Thymosin beta4: A candidate for treatment of stroke? Ann NY Acad Sci 2010; 1194: 112-7.
104. Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol 1995; 11: 73-91.
105. Graham SH, Chen J. Programmed cell death in cerebral ischemia. J Cereb Blood Flow Metab 2001; 21(2): 99-109.
106. Petcu EB, Kocher T, Kuhr A, et al. Mild systemic inflammation has a neuroprotective effect after stroke in rats. Curr Neurovasc Res 2008; 5(4): 214-23.
107. Jung KH, Roh J.K. Circulating Endothelial Progenitor Cells in Cerebrovascular Disease. J Clin Neurol 2008; 4(4): 139-47.
108. Flamme I, Frolich T, Risau W. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol 1997; 173(2): 206-10.
109. Carmeliet P, Tessier-Lavigne M. Common mechanisms of nerve and blood vessel wiring. Nature 2005; 436(7048): 193-200.
110. Yamashita T, Ninomiya M, Hernandez AP, et al. Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum. J Neurosci 2006; 26(24): 6627-36.
111. Fan Y, Shen F, Frenzel T, et al. Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann Neurol 2010; 67(4): 488-97.
112. Slevin M, Krupinski J, Badimon L. Controlling the angiogenic switch in developing atherosclerotic plaques: Possible targets for therapeutic intervention. J Angiogenes Res 2009; 1: 4.
113. Manso H, Krug T, Sobral J, et al. Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke. BMC Med Genet 2010; 11: 40.
114. Nakano-Doi A, Nakagomi T, Fujikawa M, et al. Bone marrow mononuclear cells promote proliferation of endogenous neural stem cells through vascular niches after cerebral infarction. Stem Cells 2010.
115. Plate KH, Beck H, Danner S, Allegrini PR, Wiessner C. Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct. J Neuropathol Exp Neurol 1999; 58(6): 654-66.
116. Hayashi T, Noshita N, Sugawara T, Chan P.H. Temporal profile of angiogenesis and expression of related genes in the brain after ischemia. J Cereb Blood Flow Metab 2003; 23(2): 166-80.
117. Beck H, Raab S, Copanaki E, et al. VEGFR-1 signaling regulates the homing of bone marrow-derived cells in a mouse stroke model. J Neuropathol Exp Neurol 2010; 69(2): 168-75.
118. Marti HJ, Bernaudin M, Bellail A, et al. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 2000; 156(3): 965-76.
119. Turu MM, Slevin M, Matou S, et al. C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression. BMC Cell Biol 2008; 9: 47.
120. Shimotake J, Derugin N, Wendland M, Vexler ZS, Ferriero D.M. Vascular endothelial growth factor receptor-2 inhibition promotes cell death and limits endothelial cell proliferation in a neonatal rodent model of stroke. Stroke 2010; 41(2): 343-9.
121. Mesri M, Morales-Ruiz M, Ackermann EJ, et al. Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am J Pathol 2001; 158(5): 1757-65.
122. Issa R, Krupinski J, Bujny T, et al. Vascular endothelial growth factor and its receptor, KDR, in human brain tissue after ischemic stroke. Lab Invest 1999; 79(4): 417-25.
123. Slevin M, Krupinski J, Slowik A, et al. Serial measurement of vascular endothelial growth factor and transforming growth factorbeta1 in serum of patients with acute ischemic stroke. Stroke 2000; 31(8): 1863-70.
124. Carmeliet P, Moons L, Luttun A, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001; 7(5): 575-83.
125. Beck H, Acker T, Puschel AW, et al. Cell type-specific expression of neuropilins in an MCA-occlusion model in mice suggests a potential role in post-ischemic brain remodeling. J Neuropathol Exp Neurol 2002; 61(4): 339-50.
126. Liu H, Honmou O, Harada K, et al. Neuroprotection by PlGF genemodified human mesenchymal stem cells after cerebral ischaemia. Brain 2006; 129(Pt 10): 2734-45.
127. Fuh G, Garcia KC, de Vos A.M. The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1. J Biol Chem 2000; 275(35): 26690-5.
128. Gluzman-Poltorak Z, Cohen T, Shibuya M, Neufeld G. Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes. J Biol Chem 2001; 276(22): 18688-94.
129. Leker RR, Toth ZE, Shahar T, et al. Transforming growth factor alpha induces angiogenesis and neurogenesis following stroke. Neuroscience 2009; 163(1): 233-43.
130. Krupinski J, Kumar P, Kumar S, Kaluza J. Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans. Stroke 1996; 27(5): 852-7.
131. Ata AK, Funa K, Olsson Y. Expression of various TGF-beta isoforms and type I receptor in necrotizing human brain lesions. Acta Neuropathol 1997; 93(4): 326-33.
132. Chen J, Leong SY, Schachner M. Differential expression of cell fate determinants in neurons and glial cells of adult mouse spinal cord after compression injury. Eur J Neurosci 2005; 22(8): 1895-906.
133. Fiedler LR, Bachetti T, Leiper J, et al. The ADMA/DDAH pathway regulates VEGF-mediated angiogenesis. Arterioscler Thromb Vasc Biol 2009; 29(12): 2117-24.
134. Liu XB, Wang JA, Yu SP, Keogh CL, Wei L. Therapeutic strategy of erythropoietin in neurological disorders. CNS Neurol Disord Drug Targets 2008; 7(3): 227-34.
135. Liu SP, Lee SD, Lee HT, et al. Granulocyte colony-stimulating factor activating HIF-1alpha acts synergistically with erythropoietin to promote tissue plasticity. PLoS One 2010; 5(4): E10093.
136. Anderson MF, Aberg MA, Nilsson M, Eriksson P.S. Insulin-like growth factor-I and neurogenesis in the adult mammalian brain. Brain Res Dev Brain Res 2002; 134(1-2): 115-22.
137. Beilharz EJ, Russo VC, Butler G, et al. Co-ordinated and cellular specific induction of the components of the IGF/IGFBP axis in the rat brain following hypoxic-ischemic injury. Brain Res Mol Brain Res 1998; 59(2): 119-34.
138. Lopez-Lopez C, LeRoith D, Torres-Aleman I. Insulin-like growth factor I is required for vessel remodeling in the adult brain. Proc Natl Acad Sci USA 2004; 101(26): 9833-8.
139. Denti L, Annoni V, Cattadori E, et al. Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly. Am J Med 2004; 117(5): 312-7.
140. Endres M, Piriz J, Gertz K, et al. Serum insulin-like growth factor I and ischemic brain injury. Brain Res 2007; 1185: 328-35.
141. Schaper W, Buschmann I. Arteriogenesis, the good and bad of it. Cardiovasc Res 1999; 43(4): 835-7.
142. Clayton JA, Chalothorn D, Faber J.E. Vascular endothelial growth factor-A specifies formation of native collaterals and regulates collateral growth in ischemia. Circ Res 2008; 103(9): 1027-36.
143. Schierling W, Troidl K, Troidl C, et al. The role of angiogenic growth factors in arteriogenesis. J Vasc Res 2009; 46(4): 365-74.
144. Cai W, Schaper W. Mechanisms of arteriogenesis. Acta Biochim Biophys Sin (Shanghai) 2008; 40(8): 681-92.
145. Buschmann IR, Busch HJ, Mies G, Hossmann K.A. Therapeutic induction of arteriogenesis in hypoperfused rat brain via granulocyte-macrophage colony-stimulating factor. Circulation 2003; 108(5): 610-5.
146. Todo K, Kitagawa K, Sasaki T, et al. Granulocyte-macrophage colony-stimulating factor enhances leptomeningeal collateral growth induced by common carotid artery occlusion. Stroke 2008; 39(6): 1875-82.
147. Cui X, Chopp M, Zacharek A, et al. Role of endothelial nitric oxide synthetase in arteriogenesis after stroke in mice. Neuroscience 2009; 159(2): 744-50.
148. Zacharek A, Chen J, Cui X, Yang Y, Chopp M. Simvastatin increases notch signaling activity and promotes arteriogenesis after stroke. Stroke 2009; 40(1): 254-60.
149. Chen J, Cui X, Zacharek A, et al. Niaspan treatment increases tumor necrosis factor-alpha-converting enzyme and promotes arteriogenesis after stroke. J Cereb Blood Flow Metab 2009; 29(5): 911-20.